More products

Retatrutide | 6mg

GU-P006
8950,00
грн.
Пептидні ручки
Замовити
Retatrutide is an experimental drug under development for the treatment of obesity and related metabolic disorders, such as type 2 diabetes. It acts as an agonist of multiple hormonal receptors that regulate appetite and metabolism in the body. The primary goal of Retatrutide is to aid in weight loss by reducing appetite, increasing feelings of fullness, and regulating glucose metabolism.
The mechanism of action of Retatrutide involves interaction with three hormones: GLP-1 (glucagon-like peptide-1), GIP (glucose-dependent insulinotropic peptide), and glucagon. These hormones play a key role in controlling appetite, insulin secretion, and fat breakdown.
This drug is part of a new generation of weight-loss medications being developed to provide more effective and lasting solutions for managing body weight and metabolic diseases.
This peptide offers a range of benefits, particularly in the context of weight loss and managing metabolic disorders such as type 2 diabetes. Here are the main benefits of its use:
Significant Weight Loss: Retatrutide is targeted at individuals with obesity or overweight. Clinical trials have shown that it leads to significant and sustained weight loss by reducing appetite and increasing satiety. In some studies, users have lost up to 24% of their body weight after prolonged treatment.
Improved Blood Glucose Control: Retatrutide regulates glucose metabolism, making it especially beneficial for patients with type 2 diabetes. As a GLP-1 receptor agonist, it enhances insulin secretion and improves blood glucose control, reducing post-meal glucose levels.
Regulation of Appetite and Metabolism Hormones: The drug’s mechanism of action involves activating three hormones: GLP-1, GIP, and glucagon. This helps with better appetite control and fat burning, leading to more effective weight loss.
Reduced Cardiovascular Risk: By promoting weight loss and improving metabolic profiles (blood glucose, cholesterol), Retatrutide can reduce the risk of cardiovascular diseases, which are often linked to obesity and diabetes.
Improved Lipid Profile: The medication may also help lower levels of "bad" LDL cholesterol and triglycerides, further enhancing overall health.
Potential to Treat Liver Diseases (NAFLD/NASH): Retatrutide is also being investigated for its potential benefits in treating non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH), which are associated with metabolic disorders.